One in three UK adults will be obese by 2012

December 10, 2008

One in three UK adults--or 13 million people--will be obese by 2012, finds research published ahead of print in the Journal of Epidemiology and Community Health.

And almost half of them will be from low income and disadvantaged communities, widening the health gap between the haves and have-nots even further, say the authors.

The researchers draw their conclusions on an analysis of annual data between 1993 and 2004 from the Health Survey for England.

This samples a nationally representative cross section of households, and includes information on occupation and social class.

The analysis included almost 128,000 adults with valid weight and height measurements, from which a body mass index (BMI) can be calculated. A BMI above 30 denotes obesity.

The authors then calculated the likely prevalence of obesity by 2012, using three different approaches.

These included straightforward year on year increases, and assuming that the trends remain constant; allowing for a speeding up or slowing down in the rate of change; and linear trends for the six most recent years only.

Between 1993 and 2004, the prevalence of obesity almost doubled in men, from 13.6% to 24%, and rose by almost 50% among women from 16.9% to 24.4%.

On the basis of these trends, around one in three adults (32.1% of men and 33.1% of women) will be obese by 2012, equivalent to almost 13 million people.

Of these almost half (43%) will be among low income groups and manual social classes, while the prevalence of obesity among non-manual and higher income social classes will have climbed to 35%.

At the start of this decade, 9000 people met an early death every year as a direct result of obesity, and in 2002, at an annual cost to the English economy alone of around £7.4 billion.
-end-


BMJ

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.